Toward a cure for diabetes: iPSC and ESC‐derived islet cell transplantation trials.

The article discusses the potential of iPSC and ESC-derived islet cell transplantation trials as a cure for type 1 diabetes. It highlights the challenges faced by individuals with type 1 diabetes, such as maintaining normoglycemia despite technological advancements. The text also explores recent advancements in regenerative medicine using iPSCs and ESCs for experimental cell transplantation, offering hope for a cure. Clinical trials have shown promising results, with some participants achieving insulin independence or reduced insulin requirements. The article emphasizes the ongoing research and potential for more effective and accessible treatment options for diabetes in the future. [Extracted from the article]